Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer

Oncologist

Volumn 8, Issue 1, 2003, Pages 69-75

  Ebert, Benjamin L ^a   Niemierko, Ewa ^b   Shaffer, Kitt ^a   Salgia, Ravi ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Commonwealth Hematology Oncology ^*  (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Brain metastases; Lung cancer; Temozolomide

Indexed keywords

CYTOTOXIC AGENT; ETOPOSIDE; GEMCITABINE; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN METASTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; DACARBAZINE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 0344211864     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.8-1-69     Document Type: Article

References (34)

1. Nugent J, Bunn P, Matthews M et al. CNS metastases in small cell bronchogenic carcinoma. Cancer 1979;44:1885-1893.
2. Sorensen J, Hansen H, Hansen M et al. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 1988;6:1474-1480.
3. Postmus P, Smit E. Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 1999;10:753-759.
4. Andre F, Grunenwald D, Pujol J et al. Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy. Cancer 2001;91:2394-2400.
5. Komaki R, Scott CB, Sause WT et al. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Int J Radiat Oncol Biol Phys 1997;39:537-544.
6. Law A, Karp D, Dipetrillo T et al. Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma. Cancer 2001;92:160-164.
7. Robnett TJ, Machtay M, Stevenson JP et al. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small cell lung carcinoma. J Clin Oncol 2001;19:1344-1349.
8. Nussbaum ES, Djalilian HR, Cho KH et al. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 1996;78:1781-1788.
9. Hoskin PJ, Brada M. Radiotherapy for brain metastases. Clin Oncol 2001;13:91-94.
10. Patchell R. The treatment of brain metastases. Cancer Invest 1996;14:169-177.
11. Abrey LE, Christodoulou C. Temozolomide for treating brain metastases. Semin Oncol 2001;28(suppl 13):34-42.
12. Patel M, McCully C, Godwin K et al. Plasma and cerebrospinal fluid pharmacokinetics of intrevenous temozolomide in non-human primates. J Neuro Oncol (in press).
13. Korones D, Benita-Weiss M, Lechtler L et al. A phase I study of temozolomide (temodar) and escalating doses of oral VP-16 for adults with recurrent malignant gliomas. Proc Am Soc Clin Oncol 2001;20:A2055.
14. Prados M. Temozolomide in combination with other cytotoxic agents. Semin Oncol 2001;28(suppl 13):24-33.
15. Kristensen CA, Kristjansen PE, Hansen HH. Systemic chemotherapy of brain metastases from small-cell lung cancer: a review. J Clin Oncol 1992;10:1498-1502.
16. Kleisbauer J, Vesco D, Orehek J et al. Treatment of brain metastases of lung cancer with high doses of etoposide (VP16-213). Cooperative study from the Groupe Francais Pneumo-Cancerologie. Eur J Cancer 1988;24:131-135.
17. Postmus PE, Smit E, Haaxma-Reiche H et al. Tenoposide for brain metastases of small-cell lung cancer: a phase II study. J Clin Oncol 1995;13:660-665.
18. Lee J, Murphy W, Glisson B et al. Primary chemotherapy of brain metastasis in small-cell lung cancer. J Clin Oncol 1989;7:916-922.
19. Hammond LA, Eckardt JR, Baker SD et al. Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies. J Clin Oncol 1999;17:2604-2613.
20. Biasco G, Panteleo M, Casadei S. Treatment of brain metastases of malignant melanoma with temozolomide. N Engl J Med 2001;345:621-622.
21. Abrey LE, Olson JD, Raizer JJ et al. A phase II trial of temozolimide for patients with recurrent or progressive brain metastases. J Neurooncol 2001;53:259-265.
22. Christodoulou C, Bafaloukos D, Kosmidis P et al. Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol 2001;12:249-254.
23. Antonadou D, Paraskevaidis M, Coliarakis N et al. Temozolomide enhances radiation treatment efficacy in brain metastases: a randomized phase II study. Proc Am Soc Clin Oncol 2001;20:A224.
24. Mangiameli A, Mineo G, Trovato G. Temozolimide (TMZ) in patients with brain metastases from NSCLC in combination with gemcitabine-cisplatin (GEM-COOP) or gemcitabine-vinorelbine (GEM + VNB). Proc Am Soc Clin Oncol 2001;20:A2797.
25. Postmus PE, Haaxma-Reiche H, Sleijfer DT et al. High dose etoposide for brain metastases of small cell lung cancer. A phase II trial. Br J Cancer 1989;59:254-256.
26. Twelves CJ, Souhami RL, Harper PG et al. The response of cerebral metastases in small cell lung cancer to systemic chemotherapy. Br J Cancer 1990;61:147-150.
27. Kristjansen PE, Soelberg Sorensen P, Skor Hansen M et al. Prospective evaluation of the effect on initial brain metastases from small cell lung cancer of platinum-etoposide based induction chemotherapy followed by an alternating multidrug regimen. Ann Oncol 1993;4:579-584.
28. Groen H, Smit E, Haaxma-Reiche H et al. Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer. Eur J Cancer 1993;29A:1696-1699.
29. Kaba SE, Kyritsis AP, Hess K et al. TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors. J Clin Oncol 1997;15:1063-1070.
30. Franciosi V, Cocconi G, Michiara M et al. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Cancer 1999;85:1599-1605.
31. Cotto C, Berille J, Souquet PJ et al. A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer. Eur J Cancer 1996;32A:69-71.
32. Minotti V, Crino L, Meacci ML et al. Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer. Lung Cancer 1998;20:93-98.
33. Pujol JL, Monnier A, Berille J et al. Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer. Br J Cancer 1994;69:1136-1140.
34. Vinolas N, Graus F, Mellado B et al. Phase II trial of cisplatin and etoposide in brain metastases of solid tumors. J Neurooncol 1997;35:145-148.